Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality - Concepedia

Concepedia

Publication | Open Access

Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality

DOI Full Paper Access

1.8K

Citations

36

References

2020

Year

Chi Zhang, Zhao Wu, Jiawen Li, Hong Zhao, Gui-Qiang Wang

International Journal of Antimicrobial Agents

InflammationCytokineCovid-19 PandemicImmunologyCytokine Release SyndromeImmunosuppressionCovid-19 EpidemiologyImmunotherapyMedicineCovid-19

References

	Year	Citations

Page 1